Invention Grant
- Patent Title: MDCK suspension cell lines in serum-free, chemically-defined media for vaccine production
-
Application No.: US17035451Application Date: 2020-09-28
-
Publication No.: US11672855B2Publication Date: 2023-06-13
- Inventor: Jenny Bang , Hsiao-Tzu Ni , Alan Yung-Chih Hu , Tsai-Chuan Weng
- Applicant: NATIONAL HEALTH RESEARCH INSTITUTES , FUJIFILM IRVINE SCIENTIFIC, INC.
- Applicant Address: TW CA Miaoli County
- Assignee: NATIONAL HEALTH RESEARCH INSTITUTES,FUJIFILM IRVINE SCIENTIFIC, INC.
- Current Assignee: NATIONAL HEALTH RESEARCH INSTITUTES,FUJIFILM IRVINE SCIENTIFIC, INC.
- Current Assignee Address: TW Miaoli County; US CA Santa Ana
- Agency: Foley & Lardner LLP
- Main IPC: C12N5/00
- IPC: C12N5/00 ; A61K39/145 ; A61K39/12 ; C12N5/071 ; C12N7/00 ; C12N15/85 ; A61P31/16
Abstract:
Disclosed is an adapted Madin-Darby canine kidney cell line capable of suspension culture in the absence of serum, and a chemically-defined medium for culture of the adapted MDCK cell line. Further disclosed are culture methods for growing the adapted MDCK cell line and methods for producing a vaccine from the adapted MDCK cell line grown in the chemically-defined medium.
Public/Granted literature
- US20210008194A1 MDCK SUSPENSION CELL LINES IN SERUM-FREE, CHEMICALLY-DEFINED MEDIA FOR VACCINE PRODUCTION Public/Granted day:2021-01-14
Information query
